{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:35:39Z","timestamp":1790674539124,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12264-019-00360-1","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T07:03:01Z","timestamp":1552892581000},"page":"756-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Apolipoprotein E Genotypes on Huntington\u2019s Disease Phenotypes in a Han Chinese Population"],"prefix":"10.1007","volume":"35","author":[{"given":"Xiao-Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Rong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-572X","authenticated-orcid":false,"given":"Zhi-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"360_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12264-016-0093-y","volume":"33","author":"HL Li","year":"2017","unstructured":"Li HL, Zhang YB, Wu ZY. Development of research on Huntington disease in China. Neurosci Bull 2017, 33: 312\u2013316.","journal-title":"Neurosci Bull"},{"key":"360_CR2","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2018.0911","author":"HL Li","year":"2018","unstructured":"Li HL, Li XY, Dong Y, Zhang YB, Cheng HR, Gan SR, et al. Clinical and genetic profiles in Chinese patients with Huntington\u2019s disease: a ten-year multicenter study in China. Aging Dis 2018. \n                    https:\/\/doi.org\/10.14336\/AD.2018.0911\n                    \n                  .","journal-title":"Aging Dis"},{"key":"360_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ejhg.2010.229","volume":"19","author":"SC Warby","year":"2011","unstructured":"Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL, et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 2011, 19: 561\u2013566.","journal-title":"Eur J Hum Genet"},{"key":"360_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/WNL.0000000000002858","volume":"87","author":"C Kay","year":"2016","unstructured":"Kay C, Collins JA, Miedzybrodzka Z, Madore SJ, Gordon ES, Gerry N, et al. Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology 2016, 87: 282\u2013288.","journal-title":"Neurology"},{"key":"360_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 1993, 4: 393\u2013397.","journal-title":"Nat Genet"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, et al. Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 1993, 4: 387\u2013392.","journal-title":"Nat Genet"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 1993, 4: 398\u2013403.","journal-title":"Nat Genet"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci U S A 2004, 101: 3498\u20133503.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240: 622\u2013630.","journal-title":"Science"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC, Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1: 507\u2013537.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294: 1354\u20131357.","journal-title":"Science"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","volume":"60","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 2003, 60: 1158\u20131171.","journal-title":"Cell Mol Life Sci"},{"key":"360_CR13","first-page":"338","volume":"49","author":"DM Hallman","year":"1991","unstructured":"Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991, 49: 338\u2013349.","journal-title":"Am J Hum Genet"},{"key":"360_CR14","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1073\/pnas.1207022109","volume":"109","author":"C Frieden","year":"2012","unstructured":"Frieden C, Garai K. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 2012, 109: 8913\u20138918.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"360_CR15","doi-asserted-by":"publisher","unstructured":"Guo J, Ni S, Li Q, Wang JZ, Yang Y. Folate\/Vitamin B alleviates hyperhomocysteinemia-induced Alzheimer-like pathologies in rat retina. Neurosci Bull 2018. \n                    https:\/\/doi.org\/10.1007\/s12264-018-0293-8","DOI":"10.1007\/s12264-018-0293-8"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12264-017-0148-8","volume":"34","author":"YP Wei","year":"2018","unstructured":"Wei YP, Ye JW, Wang X, Zhu LP, Hu QH, Wang Q, et al. Tau-induced Ca(2+)\/calmodulin-dependent protein kinase-IV activation aggravates nuclear tau hyperphosphorylation. Neurosci Bull 2018, 34: 261\u2013269.","journal-title":"Neurosci Bull"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.1106420108","volume":"108","author":"J Chen","year":"2011","unstructured":"Chen J, Li Q, Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci U S A 2011, 108: 14813\u201314818.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 2017, 549: 523\u2013527.","journal-title":"Nature"},{"key":"360_CR19","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 1993, 43: 1467\u20131472.","journal-title":"Neurology"},{"key":"360_CR20","unstructured":"Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer\u2019s disease. Am J Pathol 1994, 145: 1472\u20131484."},{"key":"360_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0197-4580(00)00150-0","volume":"21","author":"J Kalman","year":"2000","unstructured":"Kalman J, Juhasz A, Majtenyi K, Rimanoczy A, Jakab K, Gardian G, et al. Apolipoprotein E polymorphism in Pick\u2019s disease and in Huntington\u2019s disease. Neurobiol Aging 2000, 21: 555\u2013558.","journal-title":"Neurobiol Aging"},{"key":"360_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012, 485: 512\u2013516.","journal-title":"Nature"},{"key":"360_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s004150050406","volume":"246","author":"M Panas","year":"1999","unstructured":"Panas M, Avramopoulos D, Karadima G, Petersen MB, Vassilopoulos D. Apolipoprotein E and presenilin-1 genotypes in Huntington\u2019s disease. J Neurol 1999, 246: 574\u2013577.","journal-title":"J Neurol"},{"key":"360_CR24","first-page":"108","volume":"36","author":"P Kehoe","year":"1999","unstructured":"Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 1999, 36: 108\u2013111.","journal-title":"J Med Genet"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1399-0004.2012.01927.x","volume":"83","author":"Y Dong","year":"2013","unstructured":"Dong Y, Sun YM, Liu ZJ, Ni W, Shi SS, Wu ZY. Chinese patients with Huntington\u2019s disease initially presenting with spinocerebellar ataxia. Clin Genet 2013, 83: 380\u2013383.","journal-title":"Clin Genet"},{"key":"360_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.7150\/thno.14596","volume":"6","author":"Y Dong","year":"2016","unstructured":"Dong Y, Ni W, Chen WJ, Wan B, Zhao GX, Shi ZQ, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson\u2019s disease guides genetic diagnosis. Theranostics 2016, 6: 638\u2013649.","journal-title":"Theranostics"},{"key":"360_CR27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/45.1.143","volume":"45","author":"GG Donohoe","year":"1999","unstructured":"Donohoe GG, Salomaki A, Lehtimaki T, Pulkki K, Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem 1999, 45: 143\u2013146.","journal-title":"Clin Chem"},{"key":"360_CR28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/mds.25237","volume":"27","author":"LJ Cloud","year":"2012","unstructured":"Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, et al. Seizures in juvenile Huntington\u2019s disease: frequency and characterization in a multicenter cohort. Mov Disord 2012, 27: 1797\u20131800.","journal-title":"Mov Disord"},{"key":"360_CR29","doi-asserted-by":"crossref","unstructured":"Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F. Managing juvenile Huntington\u2019s disease. Neurodegener Dis Manag 2013, 3.","DOI":"10.2217\/nmt.13.18"},{"key":"360_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/nmt-2017-0019","volume":"7","author":"AD Moser","year":"2017","unstructured":"Moser AD, Epping E, Espe-Pfeifer P, Martin E, Zhorne L, Mathews K, et al. A survey-based study identifies common but unrecognized symptoms in a large series of juvenile Huntington\u2019s disease. Neurodegener Dis Manag 2017, 7: 307\u2013315.","journal-title":"Neurodegener Dis Manag"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1469-1809.2006.00335.x","volume":"71","author":"JM Andresen","year":"2007","unstructured":"Andresen JM, Gayan J, Djousse L, Roberts S, Brocklebank D, Cherny SS, et al. The relationship between CAG repeat length and age of onset differs for Huntington\u2019s disease patients with juvenile onset or adult onset. Ann Hum Genet 2007, 71: 295\u2013301.","journal-title":"Ann Hum Genet"},{"key":"360_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archneurol.2011.90","volume":"68","author":"D Seripa","year":"2011","unstructured":"Seripa D, Bizzarro A, Panza F, Acciarri A, Pellegrini F, Pilotto A, et al. The APOE gene locus in frontotemporal dementia and primary progressive aphasia. Arch Neurol 2011, 68: 622\u2013628.","journal-title":"Arch Neurol"},{"key":"360_CR33","doi-asserted-by":"crossref","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278: 1349\u20131356.","DOI":"10.1001\/jama.278.16.1349"},{"key":"360_CR34","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/jnnp.2003.022756","volume":"75","author":"C Saft","year":"2004","unstructured":"Saft C, Andrich JE, Brune N, Gencik M, Kraus PH, Przuntek H, et al. Apolipoprotein E genotypes do not influence the age of onset in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 2004, 75: 1692\u20131696.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"360_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.050930","volume":"44","author":"VC Wheeler","year":"2007","unstructured":"Wheeler VC, Persichetti F, McNeil SM, Mysore JS, Mysore SS, MacDonald ME, et al. Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet 2007, 44: 695\u2013701.","journal-title":"J Med Genet"},{"key":"360_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005, 6: 729\u2013742.","journal-title":"Nat Rev Genet"},{"key":"360_CR37","doi-asserted-by":"crossref","unstructured":"Al-Chalabi A, Enayat ZE, Bakker MC, Sham PC, Ball DM, Shaw CE, et al. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 1996, 347: 159\u2013160.","DOI":"10.1016\/S0140-6736(96)90343-8"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-019-00360-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:04:06Z","timestamp":1584403446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-019-00360-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s12264-019-00360-1","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"19 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors claim that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}